|
||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer |
DELTEX MEDICAL GROUP PLC |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
X |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
|
|
||
3. Full name of person(s) subject to the |
J O HAMBRO CAPITAL MANAGEMENT LIMITED |
|||
4. Full name of shareholder(s) |
|
|||
5. Date of the transaction and date on |
09 JUNE 2014 |
|||
6. Date on which issuer notified: |
10 JUNE 2014 |
|||
7. Threshold(s) that is/are crossed or |
ABOVE 5% |
|||
8. Notified details: |
||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||
GB0059337583 |
0 |
0 |
18181818 |
18181818 |
|
8.58% |
|
|||||
|
||||||||||||
|
||||||||||||
B: Qualifying Financial Instruments |
||||||||||||
Resulting situation after the triggering transaction |
||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||
|
|
|
|
|
||||||||
|
||||||||||||
Total (A+B) |
||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||
18181818 |
8.58% |
|||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
NOT APPLICABLE |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
- |
|
11. Number of voting rights proxy holder will cease |
- |
|
12. Date on which proxy holder will cease to hold |
- |
|
|
||
|
- |
|
14. Contact name: |
Mark Purnell |
|
15. Contact telephone number: |
0207 747 8952 |
|